+

WO2001088135A3 - Proteines et acides nucleiques codant pour de telles proteines - Google Patents

Proteines et acides nucleiques codant pour de telles proteines Download PDF

Info

Publication number
WO2001088135A3
WO2001088135A3 PCT/US2001/015526 US0115526W WO0188135A3 WO 2001088135 A3 WO2001088135 A3 WO 2001088135A3 US 0115526 W US0115526 W US 0115526W WO 0188135 A3 WO0188135 A3 WO 0188135A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
acids encoding
coupled receptor
protein coupled
receptor proteins
Prior art date
Application number
PCT/US2001/015526
Other languages
English (en)
Other versions
WO2001088135A2 (fr
Inventor
Muralidhara Padigaru
William M Grosse
Edward D Szerkeres
Stacie J Casman
John P Alsobrook Iii
Catherine E Burgess
Sarah Taylor
Corine A M Vernet
Jason C Baumgartner
Velizar T Tchernev
Kimberly A Spytek
Li Li
Suresh Shenoy
Ramesha Kekuda
Esha A Gangolli
David J Stone
Glennda Smithson
John R Macdougall
Original Assignee
Curagen Corp
Muralidhara Padigaru
William M Grosse
Edward D Szerkeres
Stacie J Casman
John P Alsobrook Iii
Catherine E Burgess
Sarah Taylor
Corine A M Vernet
Jason C Baumgartner
Velizar T Tchernev
Kimberly A Spytek
Li Li
Suresh Shenoy
Ramesha Kekuda
Esha A Gangolli
David J Stone
Glennda Smithson
John R Macdougall
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curagen Corp, Muralidhara Padigaru, William M Grosse, Edward D Szerkeres, Stacie J Casman, John P Alsobrook Iii, Catherine E Burgess, Sarah Taylor, Corine A M Vernet, Jason C Baumgartner, Velizar T Tchernev, Kimberly A Spytek, Li Li, Suresh Shenoy, Ramesha Kekuda, Esha A Gangolli, David J Stone, Glennda Smithson, John R Macdougall filed Critical Curagen Corp
Priority to AU2001268060A priority Critical patent/AU2001268060A1/en
Publication of WO2001088135A2 publication Critical patent/WO2001088135A2/fr
Publication of WO2001088135A3 publication Critical patent/WO2001088135A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne des séquences d'acides nucléiques codant pour les polypeptides liés au récepteur de la protéine G. L'invention concerne également les polypeptides codés par ces séquences d'acides nucléiques, et des anticorps, se liant de manière immuno-spécifique au polypeptide, ainsi que les dérivés, variants, mutants, ou fragments dudit polypeptide, ou anticorps. L'invention concerne en outre des procédés thérapeutiques, diagnostiques et de recherche pour le diagnostic, le traitement et la prévention de troubles impliquant l'un de ces acide nucléiques et protéines humains.
PCT/US2001/015526 2000-05-15 2001-05-15 Proteines et acides nucleiques codant pour de telles proteines WO2001088135A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001268060A AU2001268060A1 (en) 2000-05-15 2001-05-15 G-protein coupled receptor proteins and nucleic acids encoding same

Applications Claiming Priority (28)

Application Number Priority Date Filing Date Title
US20410600P 2000-05-15 2000-05-15
US60/204,106 2000-05-15
US22052600P 2000-07-24 2000-07-24
US60/220,526 2000-07-24
US22128800P 2000-07-27 2000-07-27
US60/221,288 2000-07-27
US25808300P 2000-12-22 2000-12-22
US60/258,083 2000-12-22
US25851500P 2000-12-28 2000-12-28
US25850800P 2000-12-28 2000-12-28
US60/258,515 2000-12-28
US60/258,508 2000-12-28
US25964201P 2001-01-04 2001-01-04
US60/259,642 2001-01-04
US26258901P 2001-01-18 2001-01-18
US60/262,589 2001-01-18
US26321401P 2001-01-22 2001-01-22
US60/263,214 2001-01-22
US26341001P 2001-01-23 2001-01-23
US60/263,410 2001-01-23
US26613001P 2001-02-02 2001-02-02
US60/266,130 2001-02-02
US27416901P 2001-03-08 2001-03-08
US60/274,169 2001-03-08
US27485901P 2001-03-09 2001-03-09
US60/274,859 2001-03-09
US27560301P 2001-03-13 2001-03-13
US60/275,603 2001-03-13

Publications (2)

Publication Number Publication Date
WO2001088135A2 WO2001088135A2 (fr) 2001-11-22
WO2001088135A3 true WO2001088135A3 (fr) 2002-08-29

Family

ID=27585091

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/015526 WO2001088135A2 (fr) 2000-05-15 2001-05-15 Proteines et acides nucleiques codant pour de telles proteines

Country Status (2)

Country Link
AU (1) AU2001268060A1 (fr)
WO (1) WO2001088135A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040106149A1 (en) * 2000-09-20 2004-06-03 Franz-Werner Kluxen Novel gpcr hfrbn63
US20020072488A1 (en) * 2000-12-12 2002-06-13 Merkulov Gennady V. Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058473A2 (fr) * 1999-03-31 2000-10-05 Curagen Corporation Acides nucleiques comprenant des phases de lecture ouverte codant des polypeptides; «orfx»
WO2001064905A2 (fr) * 2000-02-29 2001-09-07 Millennium Pharmaceuticals, Inc. 2504, 15977 et 14760, nouveaux membres de la famille proteine kinase et leurs utilisations

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058473A2 (fr) * 1999-03-31 2000-10-05 Curagen Corporation Acides nucleiques comprenant des phases de lecture ouverte codant des polypeptides; «orfx»
WO2001064905A2 (fr) * 2000-02-29 2001-09-07 Millennium Pharmaceuticals, Inc. 2504, 15977 et 14760, nouveaux membres de la famille proteine kinase et leurs utilisations

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EM_HUM EBI Hinxton, UK; 13 March 2000 (2000-03-13), BROWN A ET AL.: "Human DNA sequence of clone RP11-243J16 on chromosome 20", XP002192641 *
HERRING B P ET AL: "DOMAIN CHARACTERIZATION OF RABBIT SKELETAL MUSCLE MYOSIN LIGHT CHAIN KINASE", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 265, no. 3, 25 January 1990 (1990-01-25), pages 1724 - 1730, XP000979556, ISSN: 0021-9258 *
STADEL J M ET AL: "Orphan G protein-coupled receptors: a neglected opportunity for pioneer drug discovery", TRENDS IN PHARMACOLOGICAL SCIENCES, ELSEVIER TRENDS JOURNAL, CAMBRIDGE, GB, vol. 18, no. 11, 1 November 1997 (1997-11-01), pages 430 - 437, XP004099345, ISSN: 0165-6147 *

Also Published As

Publication number Publication date
WO2001088135A2 (fr) 2001-11-22
AU2001268060A1 (en) 2001-11-26

Similar Documents

Publication Publication Date Title
WO2002014368A8 (fr) Nouvelles proteines et acides nucleiques codant pour ces proteines
WO2002057450A3 (fr) Proteines et acides nucleiques les codant
WO2004015060A3 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et methodes d'utilisation associees
WO2002029058A3 (fr) Nouvelles proteines humaines, polynucleotides codant pour ces proteines et methodes d'utilisation associees
WO2001081578A3 (fr) Nouvelles proteines et acides nucleiques codant ces dernieres
WO2002016599A3 (fr) Nouvelles proteines et acides nucleiques les codant
WO2001074904A3 (fr) Nouvelles proteines et acides nucleiques codant pour celles-ci
WO2002046229A3 (fr) Nouvelles proteines et acides nucleiques codant celles-ci
WO2002066643A3 (fr) Proteines, polynucleotides codant pour ces proteines et procedes d'utilisation
WO2002079398A3 (fr) Polypeptides therapeutiques, les acides nucleiques les codant et leurs procedes d'utilisation
WO2002010216A3 (fr) Nouvelles proteines et acides nucleiques codant pour elles
WO2002055702A3 (fr) Protéines humaines, polynucléotides les codant et procédés d'utilisation correspondants
WO2001066747A8 (fr) Nouvelles proteines et acides nucleiques codant lesdites proteines
WO2002099116A3 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation
WO2001074851A3 (fr) Nouvelles proteines et acides nucleiques codant pour ces proteines
WO2002057452A3 (fr) Proteines, polynucleotides codant pour elles et leurs procedes d'utilisation
WO2002083841A3 (fr) Polypeptides therapeutiques, acides nucleiques les codant, et procedes d'utilisation
WO2001059113A3 (fr) Nouvelles proteines et acides nucleiques codant ces dernieres
WO2002012343A3 (fr) Nouvelles proteines et acides nucleiques les codant
WO2002026985A3 (fr) Nouvelles proteines et acides nucleiques codant ces proteines
WO2001090187A3 (fr) Nouvelles proteines et acides nucleiques codant celles-ci
WO2002008289A3 (fr) Nouvelles proteines et acides nucleiques codant ces proteines
WO2001094416A3 (fr) Nouvelles proteines et acides nucleiques qui les codent
WO2002030974A3 (fr) Nouvelles proteines et acides nucleiques codant pour celles-ci
WO2002002637A3 (fr) Nouvelles proteines et acides nucleiques les codant

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US US US US US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US US US US US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载